Chair(s): George Giannakoulas, Marion Delcroix, Mona Lichtblau
Session type: Symposium
Session content
Laurent Bertoletti
Replay
Slides
Francis Couturaud
Replay
Slides
Irene Lang
Replay
Slides
Stavros Konstantinides
Replay
Slides
Replay
Session aims
To illustrate the new approaches being developed to evaluate therapeutic candidates for pulmonary vascular disease, particularly pulmonary embolism (PE), which may be biological (e.g. with the emergence of biotherapies in the field of PE) or the development of European collaborative platforms (such as the development of multidimensional tools to predict the risk of recurrence after the first episode of PE); to focus on the treatment of patients with PE at high risk of mortality; to discuss available evidence in rare situations.